Table 1. Baseline Characteristics of the UCSF Treat Acute Study Population.
Medians with interquartile ranges and frequencies with percentages are shown.
| UCSF Treat Acute HIV Cohort | N=67 |
|---|---|
| Days from estimated HIV acquisition to ART initiation | 32.0 (22.3 – 89.8) |
| Initial CD4+ T-cell count (cells/mm3) | 505 (350 – 670) |
| Pre-ART plasma HIV RNA (log10 copies) | 4.85 (3.69 – 5.65) |
| Age | 30.0 (25.5 – 38.0) |
| Gender | |
| Male | 65 (97.0%) |
| Female | 1 (0.01%) |
| Transgender Woman | 1 (0.01%) |
| Race/ethnicity | |
| White | 21 (31.8%) |
| Latinx | 20 (30.3%) |
| Asian | 14 (21.2%) |
| Black | 10 (15.2%) |
| Other | 1 (1.5%) |
| Prior pre-exposure prophylaxis (PrEP) | 28 (41.8%) |
| HIV acquisition/PrEP overlap <10 days | 14 (20.1%) |
| PrEP initiated but already acquired HIV | 8 (11.9%) |
| HIV acquired on PrEPa | 6 (9.0%) |
| Referral HIV testing sites | |
| SF Department Public Health (%) | 28 (41.8%) |
| Community-Based Organization (%) | 29 (43.2%) |
| Private Health Clinics (%) | 10 (14.9%) |
| Unstably housed | 2 (3.0%) |
a
Median baseline plasma log10HIV RNA = 2.2 copies/mL.